111 related articles for article (PubMed ID: 2417286)
1. Isolation and characterization of substance P, substance P 5-11, and substance K from two metastatic ileal carcinoids.
Roth KA; Makk G; Beck O; Faull K; Tatemoto K; Evans CJ; Barchas JD
Regul Pept; 1985 Nov; 12(3):185-99. PubMed ID: 2417286
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
Theodorsson-Norheim E; Jörnvall H; Andersson M; Norheim I; Oberg K; Jacobsson G
Eur J Biochem; 1987 Aug; 166(3):693-7. PubMed ID: 3038549
[TBL] [Abstract][Full Text] [Related]
3. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.
Theodorsson-Norheim E; Norheim I; Oberg K; Brodin E; Lundberg JM; Tatemoto K; Lindgren PG
Biochem Biophys Res Commun; 1985 Aug; 131(1):77-83. PubMed ID: 2412557
[TBL] [Abstract][Full Text] [Related]
5. Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods.
Brodin E; Rosén A; Theodorsson E; Jonczyk A; Sandberg BE; Brodin K
Regul Pept; 1994 Jul; 52(2):97-110. PubMed ID: 7526421
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide K-(1-24)-peptide: storage and release by carcinoid tumors.
Conlon JM; Deacon CF; Grimelius L; Cedermark B; Murphy RF; Thim L; Creutzfeldt W
Peptides; 1988; 9(4):859-66. PubMed ID: 3226960
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactive tachykinins in 24-h collections of urine from patients with carcinoid tumours: characterization and correlation with plasma concentrations.
Bergstrom M; Theodorsson E; Norheim I; Oberg K
Scand J Clin Lab Invest; 1995 Dec; 55(8):679-89. PubMed ID: 8903838
[TBL] [Abstract][Full Text] [Related]
8. Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours.
Conlon JM; Deacon CF; Richter G; Schmidt WE; Stöckmann F; Creutzfeldt W
Regul Pept; 1986 Jan; 13(2):183-96. PubMed ID: 3006157
[TBL] [Abstract][Full Text] [Related]
9. Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour.
Conlon JM; Schäfer G; Schmidt WE; Lazarus LH; Becker HD; Creutzfeldt W
Regul Pept; 1985 Jun; 11(2):117-32. PubMed ID: 2412263
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of tachykinins (neuropeptide gamma, neurokinin A, and substance P) from a reptile, Alligator mississipiensis.
Wang Y; O'Harte F; Conlon JM
Gen Comp Endocrinol; 1992 Nov; 88(2):277-86. PubMed ID: 1282482
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin.
Tatemoto K; Lundberg JM; Jörnvall H; Mutt V
Biochem Biophys Res Commun; 1985 Apr; 128(2):947-53. PubMed ID: 2581573
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of multiple tachykinin immunoreactivities in bovine retina: evidence for the presence of a putative oxidative inactivation system for substance P.
Shaw C; Foy WL; Johnston CF; Buchanan KD
J Neurochem; 1989 Nov; 53(5):1547-54. PubMed ID: 2477501
[TBL] [Abstract][Full Text] [Related]
13. Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.
Conlon JM; Deacon CF; Richter G; Stöckmann F; Creutzfeldt W
Scand J Gastroenterol; 1987 Jan; 22(1):97-105. PubMed ID: 2882598
[TBL] [Abstract][Full Text] [Related]
14. Demonstration and distribution of kassinin-like material (substance K) in the rat central nervous system.
Shults CW; Yajima H; Gullner HG; Chase TN; O'Donohue TL
J Neurochem; 1985 Aug; 45(2):552-8. PubMed ID: 2409232
[TBL] [Abstract][Full Text] [Related]
15. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
[TBL] [Abstract][Full Text] [Related]
16. Tachykinin production by carcinoid tumours in culture.
Norheim I; Wilander E; Oberg K; Theodorsson-Norheim E; Lundqvist ML; Lindgren P; Bergh J
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):689-95. PubMed ID: 3477459
[TBL] [Abstract][Full Text] [Related]
17. Tachykinins (substance P and neuropeptide gamma) from the brains of the pallid sturgeon, Scaphirhynchus albus and the paddlefish, Polyodon spathula (Acipenseriformes).
Wang Y; Barton BA; Nielsen PF; Conlon JM
Gen Comp Endocrinol; 1999 Oct; 116(1):21-30. PubMed ID: 10525358
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the C-terminal flanking peptide of human beta-preprotachykinin.
McGregor GP; Conlon JM
Peptides; 1990; 11(5):907-10. PubMed ID: 2284201
[TBL] [Abstract][Full Text] [Related]
19. Tachykinins (substance P, neurokinin A and neuropeptide gamma) and neurotensin from the intestine of the Burmese python, Python molurus.
Conlon JM; Adrian TE; Secor SM
Peptides; 1997; 18(10):1505-10. PubMed ID: 9437709
[TBL] [Abstract][Full Text] [Related]
20. Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig.
Hua XY; Theodorsson-Norheim E; Brodin E; Lundberg JM; Hökfelt T
Regul Pept; 1985 Dec; 13(1):1-19. PubMed ID: 2418471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
